Artificial intelligence applied to real-world data offers potential diagnostic and therapeutic improvements for personalized cardiovascular prevention and management.
Artificial intelligence applied to real-world data offers promising avenues for personalized cardiovascular prevention and management.
Prevention and effective treatment of cardiovascular disease are progressive issues that grow in tandem with the average age of the world population. Over recent decades, the potential role of artificial intelligence in cardiovascular medicine has been increasingly recognized because of the incredible amount of real-world data (RWD) regarding patient health status and healthcare delivery that can be collated from a variety of sources wherein patient information is routinely collected, including patient registries, clinical case reports, reimbursement claims and billing reports, medical devices, and electronic health records. Like any other (health) data, RWD can be analysed in accordance with high-quality research methods, and its analysis can deliver valuable patient-centric insights complementing the information obtained from conventional clinical trials. Artificial intelligence application on RWD has the potential to detect a patient's health trajectory leading to personalized medicine and tailored treatment. This article reviews the benefits of artificial intelligence in cardiovascular prevention and management, focusing on diagnostic and therapeutic improvements without neglecting the limitations of this new scientific approach.
Ciccarelli et al. (Mon,) conducted a review in cardiovascular disease. Artificial intelligence was evaluated. Artificial intelligence applied to real-world data offers potential diagnostic and therapeutic improvements for personalized cardiovascular prevention and management.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: